Natus Medical (BABY) to Delay 10-K Filing; Prelim. Q1 Results Stronger than Views

Natus Medical Incorporated (Nasdaq: BABY) today announced that it expects to report revenue of $84 million to $86 million and non-GAAP earnings per share of $0.11 to $0.14 for the first quarter of 2013. The Company previously guided first quarter revenue of $83 million to $85 million and non-GAAP earnings per share of $0.09 to $0.10. Natus further advised that it will delay the definitive reporting of its first quarter 2013 financial results that was previously scheduled for Tuesday, May 7. The Street was looking for Q1 EPS of $0.10 and revs of $83.81 million. Natus recently implemented an ERP System that delayed the Company’s annual 10-K filing to April 10, 2013. The year-end delay has impacted the timing of the preparation and the completion of its auditor’s review of the Company’s first quarter financial report. A conference call will be scheduled to discuss the financial results upon completion of the quarterly report. “Natus had a very good first quarter as reflected in our estimated results. Both our Neurology and Newborn Care businesses performed very well,” said Jim Hawkins, Chief Executive Officer of the Company. Financial Guidance For the full year 2013, the Company now expects to report revenue of $362 million to $367 million and non-GAAP earnings per share of $0.84 to $0.87. The Company had earlier said it expected to report non-GAAP earnings per share of $0.81 to $0.84. For the second quarter of 2013, the Company expects to report revenue between $86 million to $90 million and non-GAAP earnings per share of $0.17 to $0.20. The Street sees FY13 EPS of $0.83 and revs of $364.2 million. The Company's second quarter and full year 2013 non-GAAP guidance and first quarter non-GAAP earnings estimate exclude acquisition related amortization expense and acquisition related restructuring charges and the tax effects of these items. The Company’s non-GAAP guidance includes the impact of expensing employee share based compensation. All earnings per share amounts are on a diluted basis.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Investing.com’s stocks of the week